Activation of toll‑like receptors by non‑coding RNAs and their fragments (Review)

Costa S, La Rocca G and Cavalieri V: Epigenetic regulation of chromatin functions by MicroRNAs and Long Noncoding RNAs and implications in human diseases. Biomedicines. 13:7252025. View Article : Google Scholar : PubMed/NCBI

Godden AM, Silva WTAF, Kiehl B, Jolly C, Folkes L, Alavioon G and Immler S: Environmentally induced variation in sperm sRNAs is linked to gene expression and transposable elements in zebrafish offspring. Heredity (Edinb). Mar 22–2025.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

Oliveira-Rizzo C, Colantuono CL, Fernández-Alvarez AJ, Boccaccio GL, Garat B, Sotelo-Silveira JR, Khan S, Ignatchenko V, Lee YS, Kislinger T, et al: Multi-omics study reveals Nc886/vtRNA2-1 as a positive regulator of prostate cancer cell immunity. J Proteome Res. 24:433–448. 2025. View Article : Google Scholar : PubMed/NCBI

Estravís M, García-Sánchez A, Martin MJ, Pérez-Pazos J, Isidoro-García M, Dávila I and Sanz C: RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: A possible new epigenetic mechanism of IL-13 regulation. J Physiol Biochem. 79:59–69. 2023. View Article : Google Scholar : PubMed/NCBI

Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, et al: MicroRNAs bind to Toll-like receptors to induce prometastatic inflam-matory response. Proc Natl Acad Sci USA. 109:E2110–E2116. 2012. View Article : Google Scholar : PubMed/NCBI

Wallach T, Wetzel M, Dembny P, Staszewski O, Krüger C, Buonfiglioli A, Prinz M and Lehnardt S: Identification of CNS Injury-Related microRNAs as Novel Toll-Like Receptor 7/8 Signaling Activators by Small RNA Sequencing. Cells. 9:1862020. View Article : Google Scholar : PubMed/NCBI

Greidinger EL, Zang YJ, Martinez L, Jaimes K, Nassiri M, Bejarano P, Barber GN and Hoffman RW: Differential tissue targeting of autoimmunity manifestations by autoantigen-associated Y RNAs. Arthritis Rheum. 56:1589–1597. 2007. View Article : Google Scholar : PubMed/NCBI

Oldenburg M, Krüger A, Ferstl R, Kaufmann A, Nees G, Sigmund A, Bathke B, Lauterbach H, Suter M, Dreher S, et al: TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science. 337:1111–1115. 2012. View Article : Google Scholar : PubMed/NCBI

Alvarez-Carbonell D, Garcia-Mesa Y, Milne S, Das B, Dobrowolski C, Rojas R and Karn J: Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells. Retrovirology. 14:92017. View Article : Google Scholar : PubMed/NCBI

Rodríguez-Corona JM, Ruiz Esparza-Garrido R, Horta-Vega JV and Velázquez-Flores M: Circulating Y-RNAs: A predicted function mainly in controlling the innate immune system, cell signaling and DNA replication in pediatric patients with pilocytic and diffuse astrocytoma. Clin Pediatr. 8:1–9. 2023.

Akira S, Takeda K and Kaisho T: Toll-like receptors: Critical proteins linking innate and acquired immunity. Nature Immunology. 2:675–680. 2001. View Article : Google Scholar : PubMed/NCBI

Feng Y, Zou L, Yan D, Chen H, Xu G, Jian W, Ping Cui and Chao W: Extracellular MicroRNAs induce potent innate immune responses via TLR7/MyD88-dependent mechanisms. J Immunol. 199:2106–2117. 2017. View Article : Google Scholar : PubMed/NCBI

Wiese MD, Manning-Bennett AT and Abuhelwa AY: Investigational IRAK-4 Inhibitors for the treatment of rheumatoid arthritis. Expert Opin invest Drugs. 29:475–482. 2020. View Article : Google Scholar : PubMed/NCBI

Xiao L, Liu Y and Wang N: New paradigms in inflammatory signaling in vascular endothelial cells. Am J Physiol Heart Circ Physiol. 306:H317–H325. 2014. View Article : Google Scholar : PubMed/NCBI

Van Tassell BW, Seropian IM, Toldo S, Salloum FN, Smithson L, Varma A, Hoke NN, Gelwix C, Chau V and Abbate A: Pharmacologic inhibition of myeloid differentiation factor 88 (MyD88) prevents left ventricular dilation and hypertrophy after experimental acute myocardial infarction in the mouse. J Cardiovasc Pharmacol. 55:385–390. 2010. View Article : Google Scholar : PubMed/NCBI

Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S and Medzhitov R: Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell. 118:229–241. 2004. View Article : Google Scholar : PubMed/NCBI

Tsan MF and Gao B: Endogenous ligands of Toll-like receptors. J Leukoc Biol. 76:514–519. 2004. View Article : Google Scholar : PubMed/NCBI

Rock FL, Hardiman G, Timans JC, Kastelein RA and Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA. 95:588–593. 1998. View Article : Google Scholar : PubMed/NCBI

Takeda K and Akira S: Toll-like receptors in innate immunity. Int Immunol. 17:1–14. 2005. View Article : Google Scholar : PubMed/NCBI

Mussari CP, Dodd DS, Sreekantha RK, Pasunoori L, Wan H, Posy SL, Critton D, Ruepp S, Subramanian M, Watson A, et al: Discovery of potent and orally bioavailable small molecule antagonists of toll-like receptors 7/8/9 (TLR7/8/9). ACS Med Chem Lett. 11:1751–1758. 2020. View Article : Google Scholar : PubMed/NCBI

Balak DM, van Doorn MB, Arbeit RD, Rijneveld R, Klaassen E, Sullivan T, Brevard J, Thio HB, Prens EP, Burggraaf J and Rissmann R: IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis. Clin Immunol. 174:63–72. 2017. View Article : Google Scholar : PubMed/NCBI

Patra MC, Achek A, Kim GY, Panneerselvam S, Shin HJ, Baek WY, Lee WH, Sung J, Jeong U, Cho EY, et al: A novel small-molecule inhibitor of endosomal TLRs reduces inflammation and alleviates autoimmune disease symptoms in Murine models. Cells. 9:16482020. View Article : Google Scholar : PubMed/NCBI

Winckelmann AA, Munk-Petersen LV, Rasmussen TA, Melchjorsen J, Hjelholt TJ, Montefiori D, Østergaard L, Søgaard OS and Tolstrup M: Administration of a Toll-like receptor 9 agonist decreases the pro viral reservoir in virologically suppressed HIV-infected patients. PLoS One. 8:e620742013. View Article : Google Scholar : PubMed/NCBI

Christensen S, Shupe J, Nickerson K, Kashgarian M, Flavell R and Shlomchik M: Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 25:417–428. 2006. View Article : Google Scholar : PubMed/NCBI

Komal A, Noreen M and El-Kott AF: TLR3 agonists: RGC100, ARNAX, and poly-IC: A comparative review. Immunol Res. 69:312–322. 2021. View Article : Google Scholar : PubMed/NCBI

LeNaour J, Thierry S, Scuderi SA, Boucard-Jourdin M, Liu P, Bonnin M, Pan Y, Perret C, Zhao L, Mao M, et al: A chemically defined TLR3 agonist with anticancer activity. Oncoimmunology. 12:22275102023. View Article : Google Scholar : PubMed/NCBI

Singh M, Khong H, Dai Z, Huang XF, Wargo JA, Cooper ZA, Vasilakos JP, Hwu P and Overwijk WW: Effective innate and adaptive anti-melanoma immunity through localized TLR-7/8 activation. J Immunol. 193:4722–4731. 2014. View Article : Google Scholar : PubMed/NCBI

Fuge O, Vasdev N, Allchorne P and Green JS: Immunotherapy for bladder cancer. Res Rep Urol. 7:65–79. 2015.PubMed/NCBI

Morales A, Eidinger D and Bruce AW: Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 116:180–183. 2017. View Article : Google Scholar : PubMed/NCBI

Bayraktar R, Bertilaccio MTS and Calin GA: The interaction between two worlds: MicroRNAs and Toll-like receptors. Front Immunol. 14:10532019. View Article : Google Scholar : PubMed/NCBI

Yu J, Zhang X, Cai C, Zhou T and Chen Q: Small RNA and Toll-like receptor interactions: Origins and disease mechanisms. Trends Biochem Sci. Feb 15–2025.doi: 10.1016/j.tibs.2025.01.004 (Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

He WA, Calore F, Londhe P, Canella A, Guttridge DC and Croce CM: Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci USA. 111:4525–4529. 2014. View Article : Google Scholar : PubMed/NCBI

Donzelli J, Proestler E, Riedel A, Nevermann S, Hertel B, Guenther A, Gattenlöhner S, Savai R, Larsson K and Saul MJ: Small extracellular vesicle-derived miR-574-5p regulates PGE2-biosynthesis via TLR7/8 in lung cancer. J Extracell Vesicles. 10:e121432021. View Article : Google Scholar : PubMed/NCBI

Huang X, Ma Z and Qin W: Screening and bioinformatics analyses of key miRNAs associated with Toll-like receptor activation in gastric cancer cells. Medicina (Kaunas). 59:5112023. View Article : Google Scholar : PubMed/NCBI

Clancy RM, Alvarez D, Komissarova E, Barrat FJ, Swartz J and Buyon JP: Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: A novel pathway to autoimmune-associated heart block. J Immunol. 184:2148–2155. 2010. View Article : Google Scholar : PubMed/NCBI

Li XD and Chen ZJ: Sequence specific detection of bacterial 23S ribosomal RNA by TLR13. Elife. 1:e001022012. View Article : Google Scholar : PubMed/NCBI

Krüger A, Oldenburg M, Chebrolu C, Beisser D, Kolter J, Sigmund AM, Steinmann J, Schäfer S, Hochrein H, Rahmann S, et al: Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNA. EMBO Rep. 16:1656–1663. 2015. View Article : Google Scholar : PubMed/NCBI

Yang Z, Ji S, Liu L, Liu S, Wang B, Ma Y and Cao X: Promotion of TLR7-MyD88-dependent inflammation and autoimmunity in mice through stem-loop changes in Lnc-Atg16l1. Nat Commun. 15:102242024. View Article : Google Scholar : PubMed/NCBI

Liu B, Sun Y, Geng T, Wang H, Wu Z, Xu L, Zhang M, Niu X, Zhao C, Shang J and Shang F: C5AR1-induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer. Mol Carcinog. 63:1938–1952. 2024. View Article : Google Scholar : PubMed/NCBI

Yang D, Wan X, Dennis AT, Bektik E, Wang Z, Costa MGS, Fagnen C, Vénien-Bryan C, Xu X, Gratz DH, et al: MicroRNA biophysically modulates cardiac action potential by direct binding to ion channel. Circulation. 143:1597–1613. 2021. View Article : Google Scholar : PubMed/NCBI

Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI

Wightman B, Ha I and Ruvkun G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 75:855–862. 1993. View Article : Google Scholar : PubMed/NCBI

Llave C, Kasschau KD, Rector MA and Carrington JC: Endogenous and silencing-associated small RNAs in plants. Plant Cell. 14:1605–1619. 2002. View Article : Google Scholar : PubMed/NCBI

Hansen TB, Venø MT, Jensen TI, Schaefer A, Damgaard CK and Kjems J: Argonaute-associated short introns are a novel class of gene regulators. Nat Commun. 7:115382016. View Article : Google Scholar : PubMed/NCBI

Smalheiser NR and Torvik VI: Mammalian microRNAs derived from genomic repeats. Trends Genet. 21:318–322. 2005. View Article : Google Scholar : PubMed/NCBI

Borchert GM, Lanier W and Davidson BL: RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol. 13:1097–1101. 2006. View Article : Google Scholar : PubMed/NCBI

Chung W, Agius P, Westholm JO, Chen M, Okamura K, Robine N, Leslie CS and Lai EC: Computational and experimental identification of mirtrons in Drosophila melanogaster and Caenorhabditis elegans. Genome Res. 21:286–300. 2011. View Article : Google Scholar : PubMed/NCBI

Lai EC: MicroRNAs are complementary to 3′UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet. 30:363–364. 2002. View Article : Google Scholar : PubMed/NCBI

Drinnenberg IA, Weinberg DE, Xie KT, Mower JP, Wolfe KH, Fink GR and Bartel DP: RNAi in budding yeast. Science. 326:544–550. 2009. View Article : Google Scholar : PubMed/NCBI

Zardo G, Ciolfi A, Vian L, Starnes LM, Billi M, Racanicchi S, Maresca C, Fazi F, Travaglini L, Noguera N, et al: Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood. 119:4034–4046. 2012. View Article : Google Scholar : PubMed/NCBI

Di Mauro V, Crasto S, Colombo FS, Di Pasquale E and Catalucci D: Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells. Sci Rep. 9:1–15. 2019. View Article : Google Scholar : PubMed/NCBI

Leucci E, Patella F, Waage J, Holmstrøm K, Lindow M, Porse B, Kauppinen S and Lund AH: MicroRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep. 3:25352013. View Article : Google Scholar : PubMed/NCBI

van Beijnum JR, Buurman WA and Griffioen AW: Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis. 11:91–99. 2008. View Article : Google Scholar : PubMed/NCBI

Mardente S, Mari E, Consorti F, Gioia CD, Negri R, Etna M, Zicari A and Antonaci A: HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. Oncol Rep. 28:2285–2289. 2012. View Article : Google Scholar : PubMed/NCBI

Ronkainen H, Hirvikoski P, Kauppila S, Vuopala KS, Paavonen TK, Selander KS and Vaarala MH: Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma. J Exp Clin Cancer Res. 30:842011. View Article : Google Scholar : PubMed/NCBI

Hao B, Chen Z, Bi B, Yu M, Yao S, Feng Y, Yu Y, Pan L, Di D, Luo G and Zhang X: Role of TLR4 as a prognostic factor for survival in various cancers: A meta-analysis. Oncotarget. 9:13088–13099. 2018. View Article : Google Scholar : PubMed/NCBI

Kabelitz D: Expression and function of toll-like receptors in T lymphocytes. Curr Opin Immunol. 19:39–45. 2007. View Article : Google Scholar : PubMed/NCBI

Elliott DRF, Perner J, Li X, Symmons MF, Verstak B, Eldridge M, Bower L, O'Donovan M and Gay NJ; OCCAMS Consortium; Fitzgerald RC, : Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis. PLoS Genet. 13:e10068082017. View Article : Google Scholar : PubMed/NCBI

Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, et al: Oncogenically active MYD88 mutations in human lymphoma. Nature. 470:115–119. 2011. View Article : Google Scholar : PubMed/NCBI

Li R, Hao Y, Pan W, Wang W and Min Y: Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy. Acta Biomater. 171:482–944. 2023. View Article : Google Scholar : PubMed/NCBI

Zhao BG, Vasilakos JP, Tross D, Smirnov D and Klinman DM: Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors. J Immunother Cancer. 2:122014. View Article : Google Scholar : PubMed/NCBI

Sato-Kaneko F, Yao S, Ahmadi A, Zhang SS, Hosoya T, Kaneda MM, Varner JA, Pu M, Messer KS, Guiducci C, et al: Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer. JCI Insight. 2:933972017. View Article : Google Scholar : PubMed/NCBI

Takeda Y, Kataoka K, Yamagishi J, Ogawa S, Seya T and Matsumoto M: A TLR3-specific adjuvant relieves innate resistance to PD-L1 blockade without cytokine toxicity in tumor vaccine immunotherapy. Cell Rep. 19:1874–1887. 2017. View Article : Google Scholar : PubMed/NCBI

Adams S: Toll-like receptor agonists in cancer therapy. Immunotherapy. 1:949–964. 2009. View Article : Google Scholar : PubMed/NCBI

Heil F, Hemmi H, Hochrein H, Ampeberger F, Kirchning C, Akira S, Lipford G, Wagner H and Bauer S: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 303:1526–1529. 2004. View Article : Google Scholar : PubMed/NCBI

Yoshida T, Miura T, Matsumiya T, Yoshida H, Morohashi H, Sakamoto Y, Kurose A, Imaizumi T and Hakamada K: Toll-like receptor 3 as a recurrence risk factor and a potential molecular therapeutic target in colorectal cancer. Clin Exp Gastroenterol. 13:427–438. 2020. View Article : Google Scholar : PubMed/NCBI

Bianchi F, Milione M, Casalini P, Centonze G, Le Noci VM, Storti C, Alexiadis S, Truini M, Sozzi G, Patorino U, et al: Toll-like receptor 3 as a new marker to detect high risk early stage Non-small-cell Lung Cancer patients. Sci Rep. 9:142882019. View Article : Google Scholar : PubMed/NCBI

Yuan MM, Xu YY, Chen L, Li XY, Qin J and Shen Y: TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis. BMC Cancer. 15:2452015. View Article : Google Scholar : PubMed/NCBI

Ceccarelli S, Marzolesi VP, Vannucci J, Bellezza G, Floridi C, Nocentini G, Cari L, Traina G, Petri D, Puma F and Conte C: Toll-like receptor 4 and 8 are overexpressed in lung biopsies of human Non-small cell lung carcinoma. Lung. 203:382025. View Article : Google Scholar : PubMed/NCBI

Gonzalez-Reyes S, Fernandez JM, Gonzalez LO, Aguirre A, Suarez A, Gonzalez JM, Escaff S and Vizoso FJ: Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence. Cancer Immunol Immunother. 60:217–226. 2011. View Article : Google Scholar : PubMed/NCBI

Chuang HC, Huang CC, Chien CY and Chuang JH: Toll-like receptor 3-mediated tumor invasion in head and neck cancer. Oral Oncol. 48:226–232. 2012. View Article : Google Scholar : PubMed/NCBI

Chen C, Feng Y, Zou L, Wang L, Chen HH, Cai JY, Xu JM, Sosnovik DE and Chao W: Role of extracellular RNA and TLR3-trif signaling in myocardial Ischemia-reperfusion injury. J Am Heart Assoc. 3:e0006832014. View Article : Google Scholar : PubMed/NCBI

Cabrera-Fuentes HA, Ruiz-Meana M, Simsekyilmaz S, Kostin S, Inserte J, Saffarzadeh M, Galuska SP, Vijayan V, Barba I, Barreto G, et al: RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor alpha in cardiac ischaemia/reperfusion injury. Thromb Haemost. 112:1110–1119. 2014. View Article : Google Scholar : PubMed/NCBI

Shimada BK, Yang Y, Zhu J, Wang S, Suen A, Kronstadt SM, Jeyaram A, Jay SM, Zou L and Chao W: Extracellular miR-146a-5p induces cardiac innate immune response and cardiomyocyte dysfunction. Immunohorizons. 4:561–572. 2020. View Article : Google Scholar : PubMed/NCBI

Xu J, Feng Y, Jeyaram A, Jay SM, Zou L and Chao W: Circulating plasma extracellular vesicles from septic mice induce inflammation via MicroRNA- and TLR7-Dependent mechanisms. J Immunol. 201:3392–3400. 2018. View Article : Google Scholar : PubMed/NCBI

Huang H, Zhu J, Gu L, Hu J, Feng X, Huang W, Wang S, Yang Y, Cui P, Lin SH, et al: TLR7 Mediates acute respiratory distress syndrome in sepsis by sensing extracellular miR-146a. Am J Respir Cell Mol Biol. 67:375–388. 2022. View Article : Google Scholar : PubMed/NCBI

Georges HM, Cassin C, Tong M and Abrahams VM: TLR8-activating miR-146a-3p is an intermediate signal contributing to fetal membrane inflammation in response to bacterial LPS. Immunology. 172:577–587. 2024. View Article : Google Scholar : PubMed/NCBI

Hannestad UlF, Allard A, Nilsson K and Rosén A: Prevalence of EBV, HHV6, HCMV, HAdV, SARS-CoV-2, and Autoantibodies to Type I Interferon in Sputum from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Viruses. 17:4222025. View Article : Google Scholar : PubMed/NCBI

Simpkin AJ, McNicholas BA, Hannon D, Bartlett R, Chiumello D, Dalton HJ, Gibbons K, White N, Merson L, Fan E, et al: Correction: Effect of early and later prone positioning on outcomes in invasively ventilated COVID-19 patients with acute respiratory distress syndrome: Analysis of the prospective COVID-19 critical care consortium cohort study. Ann Intensive Care. 15:442025. View Article : Google Scholar : PubMed/NCBI

Fakhraei R, Song Y, Kazi DS, Wadhera RK, Lemos JA, Das SR, Morrow DA, Dahabreh IJ, Rutan CM, Thomas K and Yeh RW: Social vulnerability and Long-term cardiovascular outcomes after COVID-19 hospitalization: An analysis of the american heart association COVID-19 registry linked with medicare claims data. J Am Heart Assoc. 14:e0380732025. View Article : Google Scholar : PubMed/NCBI

Wallach T, Raden M, Hinkelmann L, Brehm M, Rabsch D, Weidling H, Krüger C, Kettenmann H, Backofen R and Lehnardt S: Distinct SARS-CoV-2 RNA fragments activate Toll-like receptors 7 and 8 and induce cytokine release from human macrophages and microglia. Front Immunol. 13:10664562023. View Article : Google Scholar : PubMed/NCBI

Liao TL, Liu HJ, Chen DY, Tang KT, Chen YM and Liu PY: SARS-CoV-2 primed platelets-derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7/8 activation. Cell Commun Signal. 21:3042023. View Article : Google Scholar : PubMed/NCBI

Guedes JR, Santana I, Cunha C, Duro D, Almeida MR, Cardoso AM, de Lima MCP and Cardoso AL: MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease. Alzheimers Dement (Amst). 3:7–17. 2016. View Article : Google Scholar : PubMed/NCBI

Évora A, Garcia G, Rubi A, De Vitis E, Matos AT, Vaz AR, Gervaso F, Gigli G, Polini A and Brites D: Exosomes enriched with miR-124-3p show therapeutic potential in a new microfluidic triculture model that recapitulates neuron-glia crosstalk in Alzheimer's disease. Front Pharmacol. 16:14740122025. View Article : Google Scholar : PubMed/NCBI

Kazemi M, Sanati M, Shekari Khaniani M and Ghafouri-Fard S: A review on the lncRNA-miRNA-mRNA regulatory networks involved in inflammatory processes in Alzheimer's disease. Brain Res. 1856:1495952025. View Article : Google Scholar : PubMed/NCBI

Ravanidis S, Bougea A, Papagiannakis N, Koros C, Simitsi AM, Pachi I, Breza M, Stefanis L and Doxakis E: Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients. Ann Clin Transl Neurol. 7:1594–1607. 2020. View Article : Google Scholar : PubMed/NCBI

Currim F, Brown-Leung J, Syeda T, Corson M, Schumann S, Qi W, Baloni P, Shannahan JH, Rochet JC, Singh R and Cannon JR: Rotenone induced acute miRNA alterations in extracellular vesicles produce mitochondrial dysfunction and cell death. NPJ Parkinsons Dis. 11:592025. View Article : Google Scholar : PubMed/NCBI

Ishtiaq B, Paracha RZ, Nisar M, Ejaz S and Hussain Z: Discovering promising drug candidates for Parkinson's disease: Integrating miRNA and DEG analysis with molecular dynamics and MMPBSA. J Comput Aided Mol Des. 39:82025. View Article : Google Scholar : PubMed/NCBI

Wallach T, Mossmann ZJ, Szczepek M, Wetzel M, Machado R, Raden M, Miladi M, Kleinau G, Krüger C, Dembny P, et al: MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration. Mol Neurodegener. 16:802021. View Article : Google Scholar : PubMed/NCBI

Park C, Lei Z, Li Y, Ren B, He J, Huang H, Chen F, Li H, Brunner K, Zhu J, et al: Extracellular vesicles in sepsis plasma mediate neuronal inflammation in the brain through miRNAs and innate immune signaling. J Neuroinflammation. 21:2522024. View Article : Google Scholar : PubMed/NCBI

Deng L, Gao R, Chen H, Jiao B, Zhang C, Wei L, Yan C, Ye-Lehmann S, Zhu T and Chen C: Let-7b-TLR7 signaling axis contributes to the Anesthesia/Surgery-induced cognitive impairment. Mol Neurobiol. 61:1818–1832. 2024. View Article : Google Scholar : PubMed/NCBI

Wu N, Morsey BM, Emanuel KM and Fox HS: Sequence-specific extracellular microRNAs activate TLR7 and induce cytokine secretion and leukocyte migration. Mol Cell Biochem. 476:4139–4151. 2021. View Article : Google Scholar : PubMed/NCBI

Tanji H, Ohto U, Shibata T, Taoka M, Yamauchi Y, Isobe T, Miyake K and Shimizu T: Toll-like receptor 8 senses degradation products of single-stranded RNA. Nat Struct Mol Biol. 22:109–115. 2015. View Article : Google Scholar : PubMed/NCBI

Tanji H, Ohto U, Shibata T, Miyake K and Shimizu T: Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands. Science. 339:1426–1429. 2013. View Article : Google Scholar : PubMed/NCBI

Shibata T, Ohto U, Nomura S, Kibata K, Motoi Y, Zhang Y, Murakami Y, Fukui R, Ishimoto T, Sano S, et al: Guanosine and its modified derivatives are endogenous ligands for TLR7. Int Immunol. 28:211–222. 2016. View Article : Google Scholar : PubMed/NCBI

Davenne T, Bridgeman A, Rigby RE and Rehwinkel J: Deoxyguanosine is a TLR7 agonist. Eur J Immunol. 50:56–62. 2020. View Article : Google Scholar : PubMed/NCBI

Wang J, Chai J and Wang H: Structure of the mouse toll-like receptor 13 ectodomain in complex with a conserved sequence from bacterial 23S ribosomal RNA. FEBS J. 283:1631–1635. 2016. View Article : Google Scholar : PubMed/NCBI

Boccitto M and Wolin SL: Ro60 and Y RNAs: Structure, functions, and roles in autoimmunity. Crit Rev Biochem Mol Biol. 54:133–152. 2019. View Article : Google Scholar : PubMed/NCBI

Kowalski MP and Krude T: Functional roles of non-coding Y RNAs. Int J Biochem Cell Biol. 66:20–29. 2015. View Article : Google Scholar : PubMed/NCBI

Onafuwa-Nuga AA, King SR and Telesnitsky A: Nonrandom packaging of host RNAs in moloney murine leukemia virus. J Virol. 79:13528–13537. 2005. View Article : Google Scholar : PubMed/NCBI

Perreault J, Noël JF, Brière F, Cousineau B, Lucier JF, Perreault JP and Boire G: Retropseudogenes derived from the human Ro/SS-A autoantigen-associated hY RNAs. Nucleic Acids Res. 33:2032–2041. 2005. View Article : Google Scholar : PubMed/NCBI

Telesnitsky A and Wolin SL: The host RNAs in retroviral particles. Viruses. 8:1–15. 2016. View Article : Google Scholar

Haderk F, Schulz R, Iskar M, Cid LL, Worst T, Willmund KV, Schulz A, Warnken U, Seiler J, Benner A, et al: Tumor-derived exosomes modulate PD-L1 expression in monocytes. Sci Immunol. 2:eaah55092017. View Article : Google Scholar : PubMed/NCBI

Irimie AI, Zimta AA, Ciocan C, Mehterov N, Dudea D, Braicu C and Berindan-Neagoe I: The Unforeseen Non-Coding RNAs in head and neck cancer. Genes (Basel). 9:1342018. View Article : Google Scholar : PubMed/NCBI

Apolonia L, Schulz R, Curk T, Rocha P, Swanson CM, Schaller T, Ule J and Malim MH: Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1. PLoS Pathog. 11:e10046092015. View Article : Google Scholar : PubMed/NCBI

Gao FY, Pang JC, Wang M, Lu MX, Liu ZG, Cao JM, Ke XL and Yi MM: Structurally diverse genes encode TLR13 in Nile tilapia: The two receptors can recognize Streptococcus 23S RNA and conduct signal transduction through MyD88. Mol Immunol. 132:60–78. 2021. View Article : Google Scholar : PubMed/NCBI

Grote K, Nicolai M, Schubert U, Schieffer B, Troidl C, Preissner KT, Bauer S and Fischer S: Extracellular ribosomal RNA acts synergistically with Toll-like receptor 2 agonists to promote inflammation. Cells. 11:14402022. View Article : Google Scholar : PubMed/NCBI

Ren C, Cheng L, Sun Y, Zhang Q, de Haan BJ, Zhang H, Faas MM and de Vos P: Lactic acid bacteria secrete toll like receptor 2 stimulating and macrophage immunomodulating bioactive factors. J Functional Foods. 66:1037832020. View Article : Google Scholar

Kanmani P and Kim H: Protective effects of lactic acid bacteria against TLR4 induced inflammatory response in hepatoma HepG2 cells through modulation of Toll-like receptor negative regulators of Mitogen-activated protein kinase and NF-κB signaling. Front Immunol. 9:15372018. View Article : Google Scholar : PubMed/NCBI

Yamasaki-Yashiki S, Shiraishi T, Gyobu M, Sasaki H, Kunisawa J, Yokota SI and Katakura Y: Immunostimulatory activity of lipoteichoic acid with three fatty acid residues derived from Limosilactobacillus antri JCM 15950^T. Appl Environ Microbiol. 90:e01197242024. View Article : Google Scholar : PubMed/NCBI

Nishibayashi R, Inoue R, Harada Y, Watanabe T, Makioka Y and Ushida K: RNA of enterococcus faecalis Strain EC-12 Is a major component inducing Interleukin-12 production from human monocytic cells. PLoS One. 10:e01298062015. View Article : Google Scholar : PubMed/NCBI

Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, Chen R, Dean C, Dinger ME, Fitzgerald KA, et al: Long non-coding RNAs: Definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 24:430–447. 2023. View Article : Google Scholar : PubMed/NCBI

Velázquez-Flores MÁ, Rodríguez-Corona JM, López-Aguilar JE, Siordia-Reyes G, Ramírez-Reyes G, Sánchez-Rodríguez G and Ruiz Esparza-Garrido R: Noncoding RNAs as potential biomarkers for DIPG diagnosis and prognosis: XIST and XIST-210 involvement. Clin Transl Oncol. 23:501–513. 2021. View Article : Google Scholar : PubMed/NCBI

Bowman CM, Dahlberg JE, Ikemura T, Konisky J and Nomura M: Specific inactivation of 16S ribosomal RNA induced by colicin E3 in vivo. Proc Natl Acad Sci USA. 8:964–968. 1971. View Article : Google Scholar

Borek E, Baliga BS, Gehrke CW, Kuo CW, Belman S, Troll W and Waalkes TP: High turnover rate of transfer RNA in tumor tissue. Cancer Res. 37:3362–3366. 1977.PubMed/NCBI

Li S, Xu Z and Sheng J: tRNA-derived small RNA: A novel regulatory small non-coding RNA. Genes (Basel). 9:e2462018. View Article : Google Scholar

Couvillion MT, Sachidanandam R and Collins K: A growth essential Tetrahymena Piwi protein carries tRNA fragment cargo. Genes Dev. 24:2742–2747. 2010. View Article : Google Scholar : PubMed/NCBI

Pawar K, Shigematsu M, Sharbati S and Kirino Y: Infection-induced 5′-half molecules of tRNAHisGUG activate Toll-like receptor 7. PLoS Biol. 18:e30009822020. View Article : Google Scholar : PubMed/NCBI

Nicolas FE, Hall AE, Csorba T, Turnbull C and Dalmay T: Biogenesis of YRNA derived small RNAs is independent of the microRNA pathway. FEBS Lett. 586:1226–1230. 2012. View Article : Google Scholar : PubMed/NCBI

Driedonks TAP and Nolte-'t Hoen ENM: Circulating Y-RNAs in extracellular vesicles and ribonucleoprotein complexes; implications for the immune system. Front Immunol. 9:31642018. View Article : Google Scholar : PubMed/NCBI

Thompson DM, Lu C, Green PJ and Parker R: tRNA cleavage is a conserved response to oxidative stress in eukaryotes. RNA. 14:2095–2103. 2008. View Article : Google Scholar : PubMed/NCBI

Di Fazio A, Schlackow M, Pong SK, Alagia A and Gullerova M: Dicer dependent tRNA derived small RNAs promote nascent RNA silencing. Nucleic Acids Res. 50:1734–1752. 2022. View Article : Google Scholar : PubMed/NCBI

Yeung ML, Bennasser Y, Watashi K, Le SY, Houzet L and Jeang KT: Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: Evidence for the processing of a viral-cellular double stranded RNA hybrid. Nucleic Acids Res. 37:6575–6586. 2009. View Article : Google Scholar : PubMed/NCBI

Pawar K, Kawamura T and Kirino Y: The tRNA^Val half: A strong endogenous Toll-like receptor 7 ligand with a 5′-terminal universal sequence signature. Proc Natl Acad Sci USA. 121:e23195691212024. View Article : Google Scholar : PubMed/NCBI

Ventola CL: The Antibiotic Resistance Crisis Part 1: Causes and Threats. PT. 40:277–283. 2015.PubMed/NCBI

Mori V, Grant G and Hattingh L: Evaluation of antimicrobial resistance surveillance data sources in primary care setting: A scoping review. Fam Pract. 42:cmaf0132025. View Article : Google Scholar : PubMed/NCBI

Verhagen AP and Pruijn GJ: Are the Ro RNP-associated Y RNAs concealing microRNAs? Y RNA-derived miRNAs may be involved in autoimmunity. Bioessays. 33:674–682. 2011. View Article : Google Scholar : PubMed/NCBI

Hizir Z, Bottini S, Grandjean V, Trabucchi M and Repetto E: RNY (YRNA)-derived small RNAs regulate cell death and inflammation in monocytes/macrophages. Cell Death Dis. 8:e25302017. View Article : Google Scholar : PubMed/NCBI

Giraldez MD, Spengler RM, Etheridge A, Goicochea AJ, Tuck M, Choi SW, Galas DJ and Tewari M: Phospho-RNA-seq: A modified small RNA-seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma. EMBO J. 38:e1016952019. View Article : Google Scholar : PubMed/NCBI

Harharan M, Scaria V and Brahmachari SK: DbSMR: A novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinformatics. 10:1082009. View Article : Google Scholar : PubMed/NCBI

Belter A, Gudanis D, Rolle K, Piwecka M, Gdaniec Z, Naskręt-Barciszewska MZ and Barciszewski J: Mature miRNAs form secondary structure, which suggests their function beyond RISC. PLoS One. 9:e1138482014. View Article : Google Scholar : PubMed/NCBI

Du K, Liu J, Broering R, Zhang X, Yang D, Dittmer U and Lu M: Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections. Expert. Opin. Drug Discov. 13:661–670. 2018.

Christensen S, Shupe J, Nickerson K, Kashgarian M, Flavell R and Shlomchik M: Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 25:417–428. 2006. View Article : Google Scholar : PubMed/NCBI

Cheng Z, Lin P and Cheng N: HBV/HIV coinfection: Impact on the development and clinical treatment of liver diseases. Front Med (Lausanne). 8:7139812021. View Article : Google Scholar : PubMed/NCBI

Mullins SR, Vasilakos JP, Deschler K, Grigsby I, Gillis P, John J, Elder MJ, Swales J, Timosenko E, Cooper Z, et al: Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies. J Immunother Cancer. 7:2442019. View Article : Google Scholar : PubMed/NCBI

Siu L, Brody J, Gupta S, Marabelle A, Jimeno A, Munster P, Grilley-Olson J, Rook AH, Hollebecque A, Wong RKS, et al: Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors. J Immunother Cancer. 8:e0010952020. View Article : Google Scholar : PubMed/NCBI

Baba A, Wakao M, Shinchi H, Chan M, Hayashi T, Yao S, Cottam HB, Carson DA and Suda Y: Synthesis and immunostimulatory activity of sugar-conjugated TLR7 ligands. Bioorg Med Chem Lett. 30:1268402020. View Article : Google Scholar : PubMed/NCBI